C80.2
BillableMalignant neoplasm associated with transplanted organ
HCC Category Mapping
What This Code Means
Cancer that develops in an organ that was transplanted into a patient from a donor.
Coding Tips
- •Document the type of transplanted organ and the cancer type when possible
- •This code indicates post-transplant malignancy; coordinate with transplant history in medical record
Clinical Significance
Malignant neoplasm associated with transplanted organ captures cancers that develop in or are directly related to organ transplantation, including donor-transmitted malignancies and post-transplant lymphoproliferative disorder (PTLD). Transplant recipients have a 2-4 fold increased cancer risk due to chronic immunosuppression, and these malignancies often behave more aggressively. This diagnosis requires careful coordination between oncology and transplant teams regarding immunosuppression management.
Documentation Requirements
- ✓Documentation that the malignancy is associated with or arose in a transplanted organ
- ✓Type of transplant (kidney, liver, heart, lung, etc.) coded separately with Z94 codes
- ✓Specific cancer type if identifiable (code additionally if possible)
- ✓Current immunosuppression regimen and any modifications made due to the malignancy
- ✓Whether the cancer was donor-transmitted or developed de novo post-transplant
- ✓Duration since transplant to cancer diagnosis
Use Additional Code
- code to identify the specific malignancy
Code First
- complication of transplanted organ (T86.-)